News

Plant-based therapies reduce some menopause symptoms


 

FROM JAMA

References

Plant-based therapies were associated with “modest reductions” in the frequency of hot flashes and vaginal dryness in menopause, but did not significantly reduce night sweats, according to a systematic review from Dr. Oscar H. Franco and his associates.

A total of 62 studies covering 6,653 women were included in the review. Phytoestrogen use decreased vaginal dryness scores by 0.31 and reduced the number of daily hot flashes by 1.31, but did not reduce the number of night sweats. Individual phytoestrogen interventions, such as dietary and supplementary soy isoflavones, decreased vaginal dryness scores by 0.26 and reduced the number of daily hot flashes by 0.79.

©Highwaystarz-Photography/Thinkstock

While evidence was limited, Chinese medicinal herbs had no association with a reduction in menopausal symptoms, while non-Chinese medicinal herbs reduced the number of daily hot flashes by 1.62 in one randomized controlled trial.

“This review underscores the lack of data on adverse effects associated with long-term use of plant-based therapies. Information on any detrimental health effects, typically available in long-term intervention studies, is essential, given their potential relevance to postmenopausal health,” Dr. Franco and his colleagues wrote.

Read the full study in JAMA (doi: 10.1001/jama.2016.8012).

lfranki@frontlinemedcom.com

Recommended Reading

Transgender surgery making inroads
MDedge Internal Medicine
Tamoxifen cuts bleeding associated with etonogestrel contraceptive implant
MDedge Internal Medicine
HPV vaccine doesn’t provide herd immunity or crossprotection
MDedge Internal Medicine
Subclinical hypothyroidism: Treat or not?
MDedge Internal Medicine
USPSTF updates recommendations for syphilis screening
MDedge Internal Medicine
Few adverse events linked to flibanserin with self-reported alcohol use
MDedge Internal Medicine
Oral contraceptive efficacy unaffected by dimethyl fumarate
MDedge Internal Medicine
VIDEO: Romosozumab bested teriparatide in hip BMD transitioning from bisphosphonates
MDedge Internal Medicine
Study confirms role of oral contraceptives in preventing ovarian cancer
MDedge Internal Medicine
AAP, NASPAG issue joint guidance on menstruation management in teens with disabilities
MDedge Internal Medicine